Yellow Card Scheme: Difference between revisions
updated to current name of vet-related page |
Rathfelder (talk | contribs) added Category:Drug safety using HotCat |
||
| Line 33: | Line 33: | ||
[[Category:Pharmaceuticals policy]] |
[[Category:Pharmaceuticals policy]] |
||
[[Category:Pharmacy in the United Kingdom]] |
[[Category:Pharmacy in the United Kingdom]] |
||
[[Category:Drug safety]] |
|||
Revision as of 22:07, 4 September 2018
The Yellow Card Scheme is the UK system for collecting information on suspected adverse drug reactions (ADRs) to medicines. The scheme allows the safety of the medicines and vaccines that are on the market to be monitored.[1]
The Scheme was founded in 1964 after the thalidomide disaster, and was developed by Bill Inman. It is run by the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM). Suspected ADRs are collected on all licensed medicines and vaccines, from those issued on prescription to medicines bought over the counter from a pharmacist or supermarket. The Scheme also includes all herbal preparations and unlicensed medicines. ADRs can be reported by anyone; this is usually done by healthcare professionals – including doctors, pharmacists and nurses – but patients and carers can also make reports.
The sort of ADRs that should be reported are:
- ADRs that have caused death or a serious illness
- Any ADR, however minor, if associated with a new medicine or one that is under continued monitoring (highlighted in the British National Formulary (BNF) with a ▼ black triangle)
- Any ADR, however minor, if associated with a child (under 18 years of age) or in pregnancy
Yellow Cards are available from pharmacies and a few are presented near the back of the BNF as tear-off pages, copies may also be obtained by telephoning +44 (0) 808 100 3352.[2] The scheme provides forms that allow members of the public to report suspected side effects, as well as health professionals.[3]
The NHS Information Standards Board for Health and Social Care has issued an information standard for electronic submission of ADRs by IT systems.[4] This is based upon the ICS E2B (R2) international standard.[5] In July 2015 a Yellow Card smartphone app was launched for iOS and Android, allowing patients, carers and healthcare workers to report adverse reactions to medications, as well as enabling them to set up alerts for news on particular drugs and find out how many Yellow Cards a medicine has received.[6]
The Yellow Card Centre Scotland is a joint venture between MHRA and the Scottish Government.[7]
See also
- British National Formulary
- EudraVigilance
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- Pharmacovigilance
- Uppsala Monitoring Centre (WHO)
References
- ^ "The Yellow Card Scheme". Medicines and Healthcare Products Regulatory Agency. Retrieved 8 September 2014.
- ^ A side effect of your medicine? Report it using Yellow Card leaflet (2008) [full citation needed]
- ^ "Downloadable information: Reporting forms". Medicines and Healthcare Products Regulatory Agency. Retrieved 8 September 2014.
- ^ Standard ISB 1582
- ^ Maintenance of the ICH Guideline On Clinical Safety Data Management : Data Elements for Transmission of Individual Case Safety Reports E2b(R2)
- ^ "Digital evolution for ground-breaking Yellow Card Scheme" (Press release). gov.uk. 2015-07-14. Retrieved 2015-10-11.
- ^ "Yellow Card Centre Scotland". Yellow Card Centre Scotland. Retrieved 8 September 2014.